menu
    • menu

    Company profile for Invios

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Invios offers unique and highly promising new treatment options in the innovative therapy area of immuno-oncology. We are pioneers in research & development of drug candidates in cell therapies targeting new immune checkpoints and in immunomodulation.despite all efforts in cancer prevention and significant progress achieved in the availability of new treatment options for patients in the last decade, incidences and global mort...
    Invios offers unique and highly promising new treatment options in the innovative therapy area of immuno-oncology. We are pioneers in research & development of drug candidates in cell therapies targeting new immune checkpoints and in immunomodulation.despite all efforts in cancer prevention and significant progress achieved in the availability of new treatment options for patients in the last decade, incidences and global mortality rates are projected to continue to rise.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InviosAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Campus-Vienna-Biocenter 5, 1030 Vienna
    Telephone
    Telephone
    +43 1 86565 77
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.invios.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/invios-innovative-immuno-oncology/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/invIOs_com

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xenetic Biosciences Extends Collaboration With Scripps Research
    Xenetic Biosciences Extends Collaboration With Scripps Research

    19 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-19/xenetic-biosciences-inc-extends-research-and-development-collaboration-with-institute-investigator

    PHARMIWEB
    19 Nov 2025
    Share Share
    Invios to Present Oncology Pipeline Progress at JP Morgan Week
    Invios to Present Oncology Pipeline Progress at JP Morgan Week

    16 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/16/2997584/0/en/invIOs-to-present-progress-across-oncology-pipeline-during-JP-Morgan-Week-2025.html

    GLOBENEWSWIRE
    16 Dec 2024
    Share Share
    invIOs Raises €8.2 Million In Series A For Immuno-Oncology
    invIOs Raises €8.2 Million In Series A For Immuno-Oncology

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2962950/0/en/invIOs-raises-8-2-million-in-a-Series-A-to-finance-pipeline-progress-in-immuno-oncology.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    invIOs to attend JP Morgan Week in San Francisco in January
    invIOs to attend JP Morgan Week in San Francisco in January

    21 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/21/2799815/0/en/invIOs-to-attend-JP-Morgan-Week-in-San-Francisco-in-January.html

    GLOBENEWSWIRE
    21 Dec 2023
    Share Share
    invIOs starts trial of APN401, novel cell therapy against solid cancers
    invIOs starts trial of APN401, novel cell therapy against solid cancers

    05 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/05/2736966/0/en/invIOs-starts-further-clinical-trial-of-APN401-novel-cell-therapy-against-solid-cancers-and-secures-major-Austrian-grant-funding.html

    GLOBENEWSWIRE
    05 Sep 2023
    Share Share
    invIOs presents exciting preclinical data showing that immune-activating INV501
    invIOs presents exciting preclinical data showing that immune-activating INV501

    19 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/19/2690320/0/en/invIOs-presents-exciting-preclinical-data-showing-that-immune-activating-small-molecule-INV501-induces-strong-cytotoxic-activity-against-solid-tumors.html

    GLOBENEWSWIRE
    19 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search